Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;37(8):1322-35.
doi: 10.1016/j.neubiorev.2013.05.006. Epub 2013 May 20.

APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease

Affiliations
Free article
Review

APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease

Ivar Reinvang et al. Neurosci Biobehav Rev. 2013 Sep.
Free article

Abstract

Individuals carrying the *E4 allele of the apolipoprotein E gene (APOE) are at increased risk of developing Alzheimer's disease (AD). However, the biological mechanisms underlying this association are still unclear because of the complexity of the pathological processes that cause AD. Furthermore, the effect of APOE genotype on development, maintenance and aging of the normal brain is poorly understood because of the strong bias toward studying disease associations. In vivo techniques such as neuroimaging and cognitive testing offer valuable insights into the effects of APOE genotype on brain structure and function in healthy and clinical populations. We review the evidence from in vivo studies that APOE *E4, in addition to increasing the chance of age-related pathological events, is associated with age-independent non-pathological changes in brain physiology, some of which make the brain less resilient to neurodegenerative processes. We argue that the interaction between the APOE-dependent non-pathological vulnerabilities and age-related pathological changes is one mechanism that can trigger neurodegeneration, resulting in AD and other complex phenotypes.

Keywords: AD; APOE; Alzheimer's disease; ApoE; AxD; CAA; CBF; CHRNA4; CSF; Cognition; DMN; DTI; FA; FC; FDG; GWAS; Imaging; MCI; MD; MRI; Mild cognitive impairment; Neurodegeneration; PET; PiB; Pittsburgh substance B; RD; RSNs; VBM; White matter integrity; apolipoprotein E gene; apolipoprotein E protein; axonal diffusivity; cerebral amyloid angiopathy; cerebral blood flow; cerebrospinal fluid; cholinergic receptor neural nicotinic alpha chain 4 gene; default-mode network; diffusion tensor imaging; fMRI; fluoride-deoxyglucose; fractional anisotropy; functional MRI; functional connectivity; genome wide association scan; magnetic resonance imaging; mean diffusivity; mild cognitive impairment; nbM; nucleus basalis Meynert; positron emission tomography; radial diffusivity; resting state networks; voxel based morphometry.

PubMed Disclaimer

Publication types

LinkOut - more resources